Trial Profile
A Phase II Study of Maintenance Therapy With Temsirolimus in Androgen-Independent Prostate Cancer After First Line Chemotherapy With Docetaxel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Oct 2016
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Wyeth
- 21 Jun 2010 New trial record
- 04 Jun 2010 Details of trial design presented at the the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO-2010).